Ipsen and Medicis Announce Acceptance of Reloxin(R) BLA in Aesthetics (2 ) (InfoBolsa)
by FDA 19/05/2008 06:00:00 Business Wire FR0010259150 pre-clinical trials will be confirmed subsequently during clinical trials, or that the results of clinical trials will be sufficient to demonstrate the safe and effective nature of the product concerned.

(AFX UK Focus) 2008-05-15 09:14 India's Zydus Cadila gets 4 product approvals from U.S. FDA (Interactive Investor)
MUMBAI (Thomson Financial) - Indian pharmaceuticals company Zydus Cadila said it received four product approvals from the U.S. Food and Drug Administration with a market size of $6.498 billion.

St. Jude Medical Announces FDA And European CE Mark Approvals Of The IsoFlex Optim Pacing Lead (Medical News Today)
St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of the IsoFlex Optim pacing lead. The small-diameter lead is built on the proven IsoFlex pacing lead platform, and features the company's exclusive Optim insulation material. With the addition of Optim insulation to IsoFlex leads, all St.